SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-298424
Filing Date
2022-12-05
Accepted
2022-12-05 16:06:02
Documents
15
Period of Report
2022-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d431873d8k.htm   iXBRL 8-K 34683
2 EX-10.1 d431873dex101.htm EX-10.1 7419
3 EX-99.1 d431873dex991.htm EX-99.1 9887
7 GRAPHIC g431873g1205204432224.jpg GRAPHIC 4501
  Complete submission text file 0001193125-22-298424.txt   190298

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mack-20221202.xsd EX-101.SCH 2874
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20221202_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20221202_pre.xml EX-101.PRE 11277
9 EXTRACTED XBRL INSTANCE DOCUMENT d431873d8k_htm.xml XML 3391
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 221444982
SIC: 2834 Pharmaceutical Preparations